- ICH GCP
- Registre des essais cliniques de l'UE
Derniers essais
EudraCT Number: 2017-004187-35 | Sponsor Protocol Number: FACE-01 | Start Date: | |||||||||||
Sponsor Name: Falun Hospital | |||||||||||||
Full Title: The FACE (Facial nerve palsy And Cortisone Evaluation) study in children: a randomised double-blind, placebo-controlled, multicenter trial. | |||||||||||||
Medical condition: Facial Nerve Palsy (Bells Palsy) | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: SE (Ongoing) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2004-004691-37 | Sponsor Protocol Number: | Start Date: | ||||||
Sponsor Name: St Vincents University Hospital | ||||||||
Full Title: Etanercept in Psoriasis and Psoriatic Arthritis: a single center, open-label study in 15 patients. | ||||||||
Medical condition: Psoriasis and Psoriatic Arthritis | ||||||||
|
||||||||
Population Age: Adults, Elderly | Gender: Male, Female | |||||||
Trial protocol: IE (Ongoing) | ||||||||
Trial results: (No results available) |
EudraCT Number: 2016-001898-32 | Sponsor Protocol Number: V87_30 | Start Date: | |||||||||||
Sponsor Name: Seqirus UK Limited | |||||||||||||
Full Title: A Phase 2, Randomized, Observer-Blind, Multicenter Study to Evaluate the Immunogenicity and Safety of Several Doses of Antigen and MF59 Adjuvant Content in a Monovalent H5N1 Pandemic Influenza Vacc... | |||||||||||||
Medical condition: Prophylaxis for Influenza virus | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: EE (Ongoing) Outside EU/EEA | |||||||||||||
Trial results: (No results available) |